Improving Outcomes for Patients With Patients With Chronic Lymphocytic Leukemia
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
Release date: February 15, 2020
Expiration date: February 14, 2021
Estimated time to complete activity: 1.5 hours
Certified for CE by:
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
© 2020, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.
This activity is supported by an educational grant from AstraZeneca.
Amy Goodrich, CRNP, Johns Hopkins Kimmel Cancer Center
Mazyar Shadman, MD, MPH, Fred Hutchinson Cancer Research Center
The activity’s target audience will consist of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
After completing this educational activity, participants should be able to:
- Evaluate data regarding mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL)
- Devise risk-stratified treatment plans for patients with CLL
- Plan strategies for managing adverse events associated with approved therapies for CLL
Statement of Credit—Participants who successfully complete this activity (including the submission of the post-test and evaluation form) will receive a statement of credit.
Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses. Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 1.5 contact hours may be earned for successful completion of this activity
Provider is approved by the California Board of Registered Nursing, Provider No. 13664, for 1.5 contact hours.
Pharmacists. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-20-007-H01-P. This program is designated for up to 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit.
All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with the ACHS policies and procedures. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.
Ms. Goodrich has served as a consultant for Janssen Pharmaceuticals.
Dr. Shadman has received research support from Abbvie, Acerta Pharma, Beigene, Celgene, Genentech, Gilead, Merck, Mustang Biopharma, Pharacyclics, Sunesis, and TG Therapeutics.
Annenberg Center for Health Sciences at Eisenhower
Charles Willis, Director, Continuing Education, consults for Pfizer Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Lead Nurse Planner
Dorothy Caputo, MA, BSN, RN, EduPro Resources, LLC, has nothing to disclose.
Harborside and Harborside Medical Education staff have nothing to disclose.
Allyson Price, MS, PA-C, has nothing to disclose.
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.
This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
Statement of Credit
Participants who successfully complete this activity—including submission of pre-test, scoring of a minimum of 70% on the learning assessment, and submitting the completed evaluation form—will be able to download a statement of credit.
- 1.50 ACPE
- 1.50 AMA PRA Category 1 Credit(s)™
- 1.50 Attendance
- 1.50 CA-BRN
- 1.50 ANCC